In previous posts, such as here and here, I have focused on the apparent ability of pharmaceutical companies influence research, the journals that publish this research and treatment guidelines. There are many ways that drug companies can do this, including the funding and design of studies. In fact, back in July I focused on […]

Last Friday I was having breakfast with colleagues in hotel in the southwest of England. We were half way through teaching a wellness and work-life balance course to some delegates from Central and Eastern Europe. A newspaper was in evidence, and its front page warned us that, according to new recommendations, we need to […]